Barclays’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.2M Sell
659,978
-526,038
-44% -$9.7M ﹤0.01% 1046
2025
Q1
$20.7M Sell
1,186,016
-234,340
-16% -$4.09M 0.01% 728
2024
Q4
$24.6M Buy
1,420,356
+741,959
+109% +$12.9M 0.01% 705
2024
Q3
$12.6M Buy
678,397
+243,895
+56% +$4.54M ﹤0.01% 924
2024
Q2
$6.69M Sell
434,502
-200,578
-32% -$3.09M ﹤0.01% 1047
2024
Q1
$9.38M Sell
635,080
-61,804
-9% -$913K ﹤0.01% 1066
2023
Q4
$9.95M Buy
696,884
+538,674
+340% +$7.69M ﹤0.01% 1062
2023
Q3
$2.21M Sell
158,210
-710,495
-82% -$9.91M ﹤0.01% 1610
2023
Q2
$10.2M Buy
868,705
+435,312
+100% +$5.12M 0.01% 900
2023
Q1
$4.98M Sell
433,393
-383,477
-47% -$4.41M ﹤0.01% 1083
2022
Q4
$10.2M Buy
816,870
+36,711
+5% +$456K ﹤0.01% 833
2022
Q3
$10.2M Buy
780,159
+19,742
+3% +$259K 0.01% 813
2022
Q2
$10.6M Sell
760,417
-19,468
-2% -$272K 0.01% 803
2022
Q1
$11.6M Buy
779,885
+289,951
+59% +$4.32M 0.01% 822
2021
Q4
$6.63M Buy
489,934
+53,913
+12% +$730K ﹤0.01% 1079
2021
Q3
$6.42M Buy
436,021
+97,156
+29% +$1.43M ﹤0.01% 1111
2021
Q2
$6.17M Sell
338,865
-404,483
-54% -$7.36M ﹤0.01% 1125
2021
Q1
$12.9M Buy
743,348
+407,036
+121% +$7.07M 0.01% 752
2020
Q4
$5.84M Sell
336,312
-33,113
-9% -$575K ﹤0.01% 957
2020
Q3
$5.09M Buy
369,425
+28,716
+8% +$396K ﹤0.01% 960
2020
Q2
$4.92M Buy
340,709
+203,962
+149% +$2.94M ﹤0.01% 948
2020
Q1
$1.49M Sell
136,747
-533,291
-80% -$5.83M ﹤0.01% 1489
2019
Q4
$14.3M Buy
670,038
+420,007
+168% +$8.96M 0.01% 717
2019
Q3
$5.74M Sell
250,031
-38,971
-13% -$895K ﹤0.01% 1017
2019
Q2
$5.69M Buy
289,002
+89,787
+45% +$1.77M ﹤0.01% 1032
2019
Q1
$3.88M Buy
199,215
+84,125
+73% +$1.64M ﹤0.01% 1124
2018
Q4
$1.9M Sell
115,090
-59,669
-34% -$983K ﹤0.01% 1395
2018
Q3
$4.04M Buy
174,759
+119,417
+216% +$2.76M ﹤0.01% 1202
2018
Q2
$1.2M Sell
55,342
-98,244
-64% -$2.14M ﹤0.01% 1739
2018
Q1
$2.71M Buy
153,586
+112,305
+272% +$1.98M ﹤0.01% 1204
2017
Q4
$775K Buy
41,281
+25,838
+167% +$485K ﹤0.01% 1790
2017
Q3
$340K Buy
15,443
+7,656
+98% +$169K ﹤0.01% 2122
2017
Q2
$188K Sell
7,787
-37,235
-83% -$899K ﹤0.01% 2476
2017
Q1
$1.26M Sell
45,022
-1,285
-3% -$35.9K ﹤0.01% 1445
2016
Q4
$1.13M Buy
46,307
+2,929
+7% +$71.5K ﹤0.01% 1425
2016
Q3
$1.09M Sell
43,378
-2,731
-6% -$68.8K ﹤0.01% 1372
2016
Q2
$951K Buy
46,109
+35,624
+340% +$735K ﹤0.01% 1463
2016
Q1
$209K Buy
10,485
+4,116
+65% +$82K ﹤0.01% 2055
2015
Q4
$127K Sell
6,369
-818
-11% -$16.3K ﹤0.01% 2220
2015
Q3
$166K Sell
7,187
-15,303
-68% -$353K ﹤0.01% 2198
2015
Q2
$562K Sell
22,490
-40,837
-64% -$1.02M ﹤0.01% 1724
2015
Q1
$2.09M Buy
63,327
+4,409
+7% +$145K ﹤0.01% 1242
2014
Q4
$1.77M Sell
58,918
-279,173
-83% -$8.38M ﹤0.01% 1352
2014
Q3
$8.12M Buy
338,091
+301,791
+831% +$7.24M 0.01% 733
2014
Q2
$1.02M Buy
36,300
+22,943
+172% +$643K ﹤0.01% 1693
2014
Q1
$361K Sell
13,357
-32,765
-71% -$886K ﹤0.01% 2110
2013
Q4
$1.2M Sell
46,122
-5,216
-10% -$136K ﹤0.01% 1658
2013
Q3
$1.18M Sell
51,338
-9,389
-15% -$216K ﹤0.01% 1603
2013
Q2
$1.59M Buy
+60,727
New +$1.59M ﹤0.01% 1449